Languages: English - Digital Collections - National Library of Medicine Search Results

Start Over Languages English ✖ Publication Year 2020 to 2021 ✖

261. Defense health care: DOD surveys indicate beneficiary experience generally unchanged in first year of TRICARE select : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, February 2020
Subject(s):: Health Benefit Plans, Employee
Health Services Accessibility
Military Personnel
Managed Care Programs
Patient Satisfaction
United States
United States. Department of Defense

262. Preventing drug diversion: disposal of controlled substances in home hospice settings : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, April 2020
Subject(s):: Controlled Substances
Drug and Narcotic Control -- organization & administration
Hospice Care
Prescription Drug Diversion
United States

263. Anesthesia services: differences between private and Medicare payments likely due to providers' strong negotiating position : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, October 2020
Subject(s):: Anesthesia -- economics
Medicare -- economics
United States
Centers for Medicare & Medicaid Services (U.S.)

264. Science and tech spotlight: COVID-19 vaccine development

Publication:: [Washington, DC] : United States Government Accountability Office, May 2020
Subject(s):: COVID-19 Vaccines -- therapeutic use
Drug Development
United States

265. Science and tech spotlight: COVID-19 testing

Publication:: [Washington, DC] : United States Government Accountability Office, May 2020
Subject(s):: COVID-19 Testing -- methods
United States
United States. Food and Drug Administration

266. Policy for testing of alcohol (ethanol) and isopropyl alcohol for methanol, including during the public health emergency (COVID-19)

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
Subject(s):: 2-Propanol
Drug Compounding
Ethanol
Methanol
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

267. Protecting participants in bioequivalence studies for abbreviated new drug applications during the COVID-19 public health emergency

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
Subject(s):: Drug Approval
Patient Safety
Therapeutic Equivalency
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

268. COVID-19: potency assay considerations for monoclonal antibodies and other therapeutic proteins targeting SARS-CoV-2 infectivity

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
Subject(s):: Antibodies, Monoclonal
COVID-19 -- drug therapy
Enzyme-Linked Immunosorbent Assay
SARS-CoV-2
Viral Plaque Assay
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

269. Requests for feedback and meetings for medical device submissions: the Q-Submission Program : guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, January 6, 2021
Subject(s):: Device Approval
Formative Feedback
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

270. Safer technologies program for medical devices: guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, January 6, 2021
Subject(s):: Device Approval
Equipment Safety
Voluntary Programs
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

« Previous
Next »
1
2
…
23
24
25
26
27
28
29
30
31
…
134
135